Existing user? Login

Danielle Carter

Danielle Carter is house staff fellow, medicine liver diseases, Institute of Liver Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.

Recent stories

  • Transmission Electron Micrograph view (TEM) of Hepatitis B virus

    An update on the management of chronic hepatitis B and C infectionSubscription

    9 AUG 2017

    Chronic hepatitis B and C infection are leading causes of liver-related morbidity and mortality worldwide. Current therapies for chronic hepatitis B virus (HBV) infection consisting of nucleos(t)ide analogues (NA) rarely lead to functional cure. With a better understanding of the HBV lifecycle, novel agents have been developed with the hope of achieving functional cure. The development of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) therapy has led to SVR12 ra

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.